Clinical Trials Directory

Trials / Completed

CompletedNCT04472377

HPV Typing Between Self- and Physician-sampled

Evaluate the Agreement of High-risk Human Papillomavirus Type Between Self-collected Vaginal Discharge Sample Using "HygeiaTouch Self Sampling Kit for Woman" and Physician Collected Sample From the Cervix

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
1,210 (actual)
Sponsor
Hygeia Touch Inc. · Industry
Sex
Female
Age
21 Years – 65 Years
Healthy volunteers
Accepted

Summary

Hygeia Touch Inc. developed a safe and comfortable vaginal self-sampling device "Hygeia Touch Self Sampling Kit for Women" to self-collect the vaginal discharge sample for high-risk Human Papillomavirus (hrHPV) detection. This clinical trial aimed to evaluate the agreement of hrHPV detections between vaginal self-sampling using "Hygeia Touch Self Sampling Kit for Women" and physician sampling, and these results will be applied for TFDA registration approval.

Detailed description

Primary end-point: 1. Agreement of hr-HPV types, including types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and 68, between the physician-collected sample and self-collected sample 2. Agreement of the presence of hr-HPV between the physician-collected sample and self-collected sample Secondary end-point: 1. Percentage of the valid sample between self-collected and physician-collected specimens 2. Agreement of all (N = 27) HPV types between the paired samples 3. Adverse events associated with sample collection 4. Questionnaire of the appreciation and satisfaction of using self-collecting vaginal discharge sample using "Hygeia Touch Self Sampling Kit for Women" through a short movie and a brief illustration 5. Correlation between histological diagnosis and HPV types

Conditions

Interventions

TypeNameDescription
DEVICESelf sampling kit for collecting discharge from vaginal fornixA device to collect exfoliative cells from vaginal fornix that can self-operated with ease and comfort.

Timeline

Start date
2020-05-29
Primary completion
2021-12-21
Completion
2022-04-18
First posted
2020-07-15
Last updated
2024-10-03
Results posted
2024-08-12

Locations

3 sites across 1 country: Taiwan

Source: ClinicalTrials.gov record NCT04472377. Inclusion in this directory is not an endorsement.